Sawmills
Seed Round in 2025
Sawmills is a technology company that specializes in AI-driven telemetry data management. Its platform, designed for enterprises, processes and monitors data from engineering teams, enhancing reliability and quality. By identifying cost reduction opportunities and improving critical monitoring capabilities, Sawmills helps businesses manage their telemetry data efficiently and securely.
Dune Security
Seed Round in 2025
AI fighting AI.
CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens.
By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe.
Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Precision Neuroscience
Series C in 2024
Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.
Infactory
Seed Round in 2024
Infactory is a developer of an artificial intelligence search tool aimed at providing reliable and accurate search results. The company's platform integrates high-quality data partnerships with both conventional and cutting-edge technologies. This combination enables users to access clear, precise, and trustworthy information efficiently, eliminating unnecessary complexities.
Distributional
Series A in 2024
Distributional develops an adaptive testing platform for enterprise AI applications. It offers tools for continuous monitoring, generating test cases, and analyzing results to ensure artificial intelligence systems function reliably and securely.
Centaur Labs
Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Bionic Health
Seed Round in 2024
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.
BeyondTrucks
Series A in 2024
BeyondTrucks streamlines real-time fleet operations for private and specialty trucking companies. Its configurable platform automates processes and optimizes decisions, replacing outdated software and manual methods.
Multiscale Technologies
Series A in 2024
Multiscale Technologies offers an AI platform designed to accelerate research and development and the discovery of new materials. The platform digitizes diverse data sources—including tabular data, PDFs, and simulations—and uses a proprietary knowledge fusion approach to connect experiments, simulations, and materials-domain expertise. It delivers predictive analyses and recommendations for manufacturing companies involved in R&D for new materials. Described as a no-code platform, it enables creation of high-fidelity models that drive innovation across research domains by linking experiments, simulations, and domain know-how through data-driven fusion.
Clarium Health
Venture Round in 2024
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
Consensus
Series A in 2024
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Sawmills
Seed Round in 2024
Sawmills is a technology company that specializes in AI-driven telemetry data management. Its platform, designed for enterprises, processes and monitors data from engineering teams, enhancing reliability and quality. By identifying cost reduction opportunities and improving critical monitoring capabilities, Sawmills helps businesses manage their telemetry data efficiently and securely.
Hopscotch Primary Care
Series C in 2024
Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.
caVos biotherapeutics
Seed Round in 2024
An emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms
Multitude Insights
Seed Round in 2024
Founded in 2021, Multitude Insights is a technology company based in Watertown, Massachusetts. It specializes in developing platforms that enhance collaboration among public safety agencies by providing intelligent bulletin management and real-time data analysis, ultimately improving case resolution.
NobleAI employs Science-Based AI technology to help businesses accelerate the development of superior chemical and material products. This approach reduces costs, enhances sustainability, and ensures reliable sourcing.
Truleo uses AI to analyze police body camera footage nationwide. It automatically detects critical events like use-of-force incidents and reviews officer language, enabling supervisors to provide targeted coaching or praise.
Founded in 2018, Ocient develops a high-performance data analytics platform designed for rapid analysis of massive datasets. Its platform efficiently handles large datasets measured in terabytes, petabytes, or exabytes with trillions or quadrillions of rows, enabling organizations to harness the power of big data at scale and velocity.
Mineral Forecast
Seed Round in 2024
Mineral Forecast is a technology company that specializes in enhancing mineral exploration through the application of artificial intelligence. It has developed a drilling support system that digitally transforms the exploration process by analyzing drilling data. This system enables mining companies to quantitatively assess and prioritize potential drilling sites, thereby optimizing their exploration efforts. By leveraging advanced AI algorithms, Mineral Forecast helps to accelerate resource discovery, reduce operational costs associated with drilling campaigns, and improve the overall success rate of exploration projects. The company's innovative approach aims to make mineral exploration more efficient and effective for mining operations.
Alvee offers an AI-driven tool for healthcare providers and payers. It assesses patients' health equity status by considering social determinants of health, chronic conditions, demographics, and health inequity risks. This enables better patient care and helps meet data stratification quality reporting requirements.
Lightbeam.ai
Series A in 2024
LightBeam.ai is a leading innovator in data security and privacy automation, dedicated to helping organizations manage and access sensitive data securely. The company's platform utilizes advanced data management techniques, including entity linkage and deep learning, to efficiently scan and comprehend documents, speech, and natural language processing at scale. This technology operates seamlessly across various third-party virtual clouds or managed services, allowing clients to integrate data from diverse sources and generate actionable insights while safeguarding data privacy and confidentiality. LightBeam.ai empowers privacy and compliance executives to maintain continuous compliance, while also providing information security executives with assurance that sensitive data is accessed and utilized securely. Through its identity-centric discovery and classification engine, LightBeam integrates data cataloging, access, and sharing into a cohesive privacy control system.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Hayden AI
Series B in 2023
Hayden AI develops artificial intelligence and machine learning technologies for automated enforcement in dedicated bus lanes and stops. Their platform aims to enhance public transit efficiency, improve street safety, and promote sustainable urban mobility.
Clarium Health
Seed Round in 2023
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
OpsLab designs predictive operations tracking platforms and disruption management systems for global defense organizations, airlines, and hospitals.
CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.
OfferFit is an AI-powered platform that automates decision-making and personalization for businesses. It optimizes customer engagement strategies by continuously testing and learning from various offers, delivering tailored recommendations to improve marketing effectiveness and customer experience.
Graft offers a modern AI platform that empowers data teams to create production-ready AI solutions with minimal effort. It leverages foundation models and requires no machine learning expertise, additional hiring, or infrastructure maintenance.
Ellipsis Health
Series A in 2023
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Kolors is a technology company that specializes in enhancing intercity bus transportation through an AI-enabled smart bus platform. The platform leverages artificial intelligence and data analytics to deliver a range of services, including route optimization, virtual stops, scheduling, and dynamic pricing. Additionally, it incorporates digital payment solutions and GPS tracking, alongside CCTV for security enhancements, which together facilitate a more efficient and safer travel experience. By providing these innovative tools, Kolors aims to support small and medium bus operators in improving their operational efficiency and revenue generation, while also enhancing the overall experience for passengers.
Jirav is a cloud-based financial forecasting and analysis platform that connects financial and operational data to enable planning, reporting, and scenario analysis. The software lets users explore historical operations and forecast bookings, revenues, headcount, expenses, and cash flows, while providing plan versus actual views and rolling forecasts. It supports interactive reports, data visualization, and easy sharing to align teams across departments. The platform offers templates to help build accurate budgets and forecasts, and is designed for finance teams, accounting firms, and business leaders who need rapid deployment of a corporate planning and analytics function. Founded in 2015 and headquartered in San Francisco, Jirav positions itself as FP&A as a Service, delivering powerful analysis, reporting, and forecasting capabilities to enable fast, informed decision making.
AlliConnect
Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%!
Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
Dune Security
Pre Seed Round in 2023
AI fighting AI.
CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens.
By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe.
Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Limitless
Series A in 2023
Limitless is a technology company focused on developing advanced artificial intelligence solutions. They develop AI-driven products to improve productivity, streamline processes, and deliver insights for businesses. Limitless serves a broad range of industries, from retail and finance to healthcare and logistics, providing AI solutions that are tailored to the unique needs of each sector.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
NobleAI employs Science-Based AI technology to help businesses accelerate the development of superior chemical and material products. This approach reduces costs, enhances sustainability, and ensures reliable sourcing.
Bionic Health
Seed Round in 2023
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.
Precision Neuroscience
Series B in 2023
Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.
Beekin provides prescriptive analytics for multifamily real estate operations via an analytics platform designed for institutional-scale investment management. The platform delivers real-time insights, valuations, contract management, accounting, reporting, and analytics to help multifamily and single-family investors harness data to make informed real estate decisions. Backed by a team of urban economists, data scientists, and ex-real estate investors, Beekin combines data science with market expertise to improve asset performance and operational efficiency. The company emphasizes collaboration and transparency to drive better outcomes in the real estate sector.
Solvo.ai
Seed Round in 2022
Solvo.ai offers a machine learning-driven platform that empowers carriers and freight forwarders to optimize pricing strategies. Its core product, the Price Optimisation Engine, enables trade management teams to adapt swiftly to market fluctuations and customer needs, facilitating real-time price adjustments aligned with business objectives.
Multiscale Technologies
Venture Round in 2022
Multiscale Technologies offers an AI platform designed to accelerate research and development and the discovery of new materials. The platform digitizes diverse data sources—including tabular data, PDFs, and simulations—and uses a proprietary knowledge fusion approach to connect experiments, simulations, and materials-domain expertise. It delivers predictive analyses and recommendations for manufacturing companies involved in R&D for new materials. Described as a no-code platform, it enables creation of high-fidelity models that drive innovation across research domains by linking experiments, simulations, and domain know-how through data-driven fusion.
Kalderos
Venture Round in 2022
Kalderos, Inc. is a healthcare technology company that specializes in drug discount management solutions. Founded in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and optimize the coordination of drug discount programs for healthcare providers, manufacturers, and payers. The platform employs advanced models and machine learning processes to identify and resolve non-compliance issues, detect inconsistencies, and provide data management capabilities. By offering features such as claims verification, dispute resolution, and discount monitoring, Kalderos enables its clients to streamline the communication and payment processes associated with drug discounts, ultimately eliminating waste and enhancing efficiency in the healthcare system.
Knowde is the leading software platform for the chemical industry. It connects global producers and distributors using the world's largest purpose-built chemical taxonomy, enabling digital transformation and improved operations.
Moving Analytics
Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Veritonic
Series A in 2022
Veritonic offers a comprehensive audio analytics platform that enables businesses to measure, compare, and optimize the impact of their audio content such as music, videos, voiceovers, jingles, and audio logos. By providing AI-driven metrics and marketing response data, Veritonic helps clients make informed decisions about their audio investments, mitigate risks through optimization, and enhance consumer engagement.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health is a health technology company that provides a cloud-based analytics platform for healthcare providers to analyze electronic health records and patient messaging data in real time. The platform uses machine learning to identify potential health risks and to predict infections, injuries, and other harms before symptoms appear, enabling proactive patient care and support for preventive medicine.
BeyondTrucks
Seed Round in 2022
BeyondTrucks streamlines real-time fleet operations for private and specialty trucking companies. Its configurable platform automates processes and optimizes decisions, replacing outdated software and manual methods.
GridMatrix
Seed Round in 2022
GridMatrix develops software that helps cities optimize their intersection infrastructure. By harnessing real-time insights from existing cameras and sensors, GridMatrix enables efficient traffic management, reducing congestion, emissions, and accidents.
ODAIA is a technology company offering an AI-powered customer data platform for the life sciences industry. Its platform blends data analysis, process mining, and artificial intelligence to deliver goal-driven commercial insights and automate processes as a software-as-a-service. It supports personalized selling by helping pharmaceutical teams map customer journeys and optimize engagement to ensure therapeutics reach patients who need them.
Curbside Health
Seed Round in 2022
Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%!
Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%!
Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
OfferFit is an AI-powered platform that automates decision-making and personalization for businesses. It optimizes customer engagement strategies by continuously testing and learning from various offers, delivering tailored recommendations to improve marketing effectiveness and customer experience.
TripleBlind
Series A in 2021
Founded in 2019, TripleBlind operates an online platform enabling entities to collaborate on sensitive data and algorithms without compromising privacy. Its software-only solution, delivered via API, focuses on healthcare and financial services, supporting various data types and cloud platforms. Backed by Accenture, General Catalyst, and Mayo Clinic, TripleBlind ensures compliance with HIPAA and GDPR.
Civis Analytics
Series B in 2021
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools and services, including the Civis platform for predictive analytics, which facilitates end-to-end data workflows. The company's offerings include the Community Outreach and Engagement Hub, designed for government and nonprofit teams to effectively reach and engage their target audiences; the Census Intelligence Center, which aids census coordinators and leadership; and various tools for audience targeting and message testing. Additionally, Civis provides data science consulting, consumer insights, market research, and media optimization services. By combining advanced software solutions with expertise in data science and survey methodology, Civis Analytics helps both public and private sector organizations enhance their decision-making processes and achieve a competitive edge.
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.
Nixtla
Pre Seed Round in 2021
Nixtla is a company that specializes in providing advanced forecasting tools and software development platforms for businesses across various industries. Its mission is to democratize access to data-driven decision-making by enabling organizations of all sizes to harness the power of sophisticated algorithms and predictive analytics. Nixtla's platform allows developers and data scientists to build open-source forecasting software, facilitating the creation of time series processing services in the cloud. By utilizing continuous integration and deployment, clients can efficiently deploy APIs and develop features tailored to their temporal data needs. The company's focus on cutting-edge forecasting and anomaly detection empowers users to reduce uncertainty and enhance their decision-making capabilities, regardless of their team's size or technical expertise.
Hayden AI
Series A in 2021
Hayden AI develops artificial intelligence and machine learning technologies for automated enforcement in dedicated bus lanes and stops. Their platform aims to enhance public transit efficiency, improve street safety, and promote sustainable urban mobility.
Shakudo
Seed Round in 2021
Shakudo develops an end-to-end machine learning platform that moves AI work from ideation to production, enabling data science and ML teams to deliver products rather than experiments. The platform accelerates development by scaling up and customizing clusters with a single line of code and by ensuring compatibility across data tools, producing a reliable, performant, and cost-effective data stack. By reducing reliance on engineers, it helps teams operationalize research faster and bring AI solutions to market.
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.
Pave helps consumer and SMB credit risk teams increase approvals through AI-powered cashflow analytics.
100 million+ US consumers and businesses are financially underserved, simply because their data is not recognized by the traditional financial system.
We solve this by transforming transaction data, loan performance outcomes, and credit reports into Cashflow-driven Attributes and Scores, enabling increased financial access to new customer segments without increasing risk.
Our mission is to build a future where every person and business has access to equitable credit solutions by creating a new standard of Cashflow-driven Analytics.
Zone7
Convertible Note in 2021
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
AllHere Education
Series A in 2021
AllHere, Inc. is a Boston-based company that focuses on reducing chronic absenteeism in K-12 schools through its intervention management platform. The platform offers various tools, including referral management to analyze chronic absence data at multiple levels, intervention tracking applications for monitoring attendance interventions such as home visits and mentoring, and automated analytics reports to assess the effectiveness of intervention programs. Additionally, AllHere employs artificial intelligence and supervised machine learning to enhance its chatbot software, facilitating real-time, one-on-one communication between schools and families. This approach aims to create engaging experiences that support student recruitment, retention, and success by providing timely assistance and information to families.
Intrinio is a financial data company that provides an API‑based platform designed to make financial information affordable and easily accessible. The service offers a wide range of data feeds, including fundamentals, economic indicators, insider transactions, institutional holdings, executive compensation, stock and options prices, and earnings estimates. By delivering data from SEC filings and other sources in user‑friendly formats, Intrinio enables investors and developers to focus on analysis and innovation rather than data collection and entry. The company’s marketplace model connects data providers, developers, and investors, fostering a more efficient and developer‑centric financial data ecosystem.
Datanomix
Series A in 2021
Datanomix, Inc. is a software company based in Nashua, New Hampshire, established in 2015. It specializes in providing a machine data analytics platform that delivers real-time insights into manufacturing productivity for industrial manufacturers. The company's software integrates machine data streams, extending its functionality beyond conventional data visualization and process productivity tools. This allows manufacturers of all sizes to access advanced decision-making resources, thereby enhancing their production efficiency, performance, and profitability. By focusing on production intelligence, Datanomix aims to support the next generation of manufacturing environments.
Intus Care
Seed Round in 2021
Founded in 2018, Intus Care develops a platform that connects home care providers with patients. Its application uses machine learning to predict hospital readmissions and risks, enabling efficient tracking of care providers and high-risk patient identification.
PulseData AI
Series A in 2021
PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted care, and ultimately reduce preventable illnesses and medical costs.
Scipher Medicine
Series C in 2021
Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.
Hayden AI
Seed Round in 2021
Hayden AI develops artificial intelligence and machine learning technologies for automated enforcement in dedicated bus lanes and stops. Their platform aims to enhance public transit efficiency, improve street safety, and promote sustainable urban mobility.
Lang.ai
Seed Round in 2021
Founded in 2012, Lang.ai is a Madrid-based company with offices in the U.S. and Mexico. It develops an online application that processes and analyzes scalable language data from social networks, automating tagging and categorization of customer interactions to uncover new patterns.
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.
Founded in 2018, Ocient develops a high-performance data analytics platform designed for rapid analysis of massive datasets. Its platform efficiently handles large datasets measured in terabytes, petabytes, or exabytes with trillions or quadrillions of rows, enabling organizations to harness the power of big data at scale and velocity.
Mage is a developer of an open-source coding tool that empowers businesses to leverage artificial intelligence for predictive analytics. The platform enables users to create and deploy machine-learning models efficiently, allowing for applications in areas such as churn prevention, product recommendations, and customer lifetime value assessment. By facilitating the import and transformation of data from various sources, Mage's technology simplifies the process of building, training, and integrating data into applications. The company's mission is to make AI technology accessible, enabling businesses to enhance customer experiences through innovative solutions.
FULLFILL
Seed Round in 2021
FULLFILL is a digital platform offering virtual health coaching programs designed to prevent and treat chronic conditions. It partners with employers worldwide to improve employee health and reduce medical expenses. The platform offers evidence-based content, daily support from Master Coaches, and engages employees effectively, doubling medical results compared to traditional programs.
Conversa Health
Series B in 2021
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Ellipsis Health
Seed Round in 2021
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
OmniPanel
Seed Round in 2020
OmniPanel is an analytics platform designed to extract valuable insights from customer support tickets. By analyzing user interactions, the platform helps businesses identify points of friction that affect customer retention and profitability. OmniPanel's approach emphasizes collaboration within a unified workspace, allowing organizations to prioritize the customer's voice in their decision-making processes. This capability enables businesses to enhance their customer experience and make data-driven product decisions, ultimately leading to more effective customer service and improved engagement.
FreightFlows
Venture Round in 2020
Founded in 2018 and headquartered in Boston, FreightFlows provides a data-driven platform offering predictive analytics for global maritime trade. Its platform enables users to optimize operational decisions by analyzing market trends, vessel availability, routes, and commodity cargo activities.
Civis Analytics
Series A in 2020
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools and services, including the Civis platform for predictive analytics, which facilitates end-to-end data workflows. The company's offerings include the Community Outreach and Engagement Hub, designed for government and nonprofit teams to effectively reach and engage their target audiences; the Census Intelligence Center, which aids census coordinators and leadership; and various tools for audience targeting and message testing. Additionally, Civis provides data science consulting, consumer insights, market research, and media optimization services. By combining advanced software solutions with expertise in data science and survey methodology, Civis Analytics helps both public and private sector organizations enhance their decision-making processes and achieve a competitive edge.
Chooch specializes in generative AI technology that integrates computer vision and language understanding to create intelligent camera systems. Their AI Vision platform analyzes video streams in real-time, detecting visuals and actions, comprehending their significance, and triggering pre-programmed responses swiftly. This technology is designed to process a wide range of visual data, from infrared radiation sensors and x-rays to various applications, tagging objects of interest. Chooch's solutions aim to enhance efficiencies and ensure quality results for clients across different industries.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Usermind, Inc. is a technology company that specializes in creating a unified orchestration platform aimed at enhancing business operations and customer experiences. Founded in 2013 and headquartered in Seattle, Washington, Usermind addresses the challenges posed by siloed enterprise systems and fragmented customer data. Its platform integrates various SaaS applications and on-premise systems, facilitating entity mapping and the automation of complex customer journeys. By providing a customer data platform alongside a customer journey orchestration engine and analytics capabilities, Usermind enables organizations to deliver data-driven, omnichannel engagement throughout the customer lifecycle. This comprehensive approach empowers businesses to increase revenue, enhance customer engagement, and optimize costs.
Founded in 2018 by Joe Schaeppi (CEO) and Bastian Bergmann (COO), Solsten is a Berlin-based AI company specializing in understanding human behavior within digital environments. Its platform, used by key decision-makers across various industries including gaming and medium-to-large studios, leverages AI to analyze psychological traits and behaviors, enabling personalized marketing strategies, content creation, and customer engagement.
Perennial
Venture Round in 2020
Cloud Agronomics Inc. is a geospatial imaging and analytics company that specializes in providing real-time analytics and predictive insights regarding crop performance to enhance agricultural practices. Founded in 2017 and headquartered in Lewes, Delaware, the company utilizes remote sensing technology to deliver actionable farm management insights. Its offerings include carbon monitoring, digital agronomy, and yield predictions, enabling farmers to identify and address crop disease outbreaks effectively. By providing these advanced analytical tools, Cloud Agronomics aims to optimize agricultural productivity and sustainability.
Kolors is a technology company that specializes in enhancing intercity bus transportation through an AI-enabled smart bus platform. The platform leverages artificial intelligence and data analytics to deliver a range of services, including route optimization, virtual stops, scheduling, and dynamic pricing. Additionally, it incorporates digital payment solutions and GPS tracking, alongside CCTV for security enhancements, which together facilitate a more efficient and safer travel experience. By providing these innovative tools, Kolors aims to support small and medium bus operators in improving their operational efficiency and revenue generation, while also enhancing the overall experience for passengers.
Conversa Health
Venture Round in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Conversa Health
Series B in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Betterview
Convertible Note in 2020
Betterview is a property intelligence platform that enables property and casualty insurers to effectively analyze, score, manage, and monitor property risk. By leveraging geospatial data and proprietary machine learning technology, Betterview transforms complex data into actionable insights, enhancing decision-making throughout the policy lifecycle. The platform aims to identify and mitigate risks while improving operational efficiency and inspection processes. Additionally, it fosters a more transparent customer experience, allowing insurers to automate critical functions such as pricing, underwriting, and renewal. Through its innovative approach, Betterview supports insurers in focusing their strategic efforts on high-risk properties, thereby enhancing overall risk management.
Attest
Venture Round in 2020
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.
RapidSOS
Venture Round in 2020
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Adventr
Venture Round in 2020
Adventr offers a SaaS platform for designing, distributing, and analyzing interactive video content. Its flagship product enables users to create viewer-driven videos with real-time choices, enhancing engagement metrics. Content can be embedded or distributed via ad networks and publishers.
Founded in Berlin in 2014, Teraki develops software solutions that enable high-volume, real-time data processing for connected car applications. Its platform facilitates predictive maintenance, usage-based insurance (UBI), fleet management, and autonomous driving services by optimizing data compression and latency.
Usermind
Venture Round in 2019
Usermind, Inc. is a technology company that specializes in creating a unified orchestration platform aimed at enhancing business operations and customer experiences. Founded in 2013 and headquartered in Seattle, Washington, Usermind addresses the challenges posed by siloed enterprise systems and fragmented customer data. Its platform integrates various SaaS applications and on-premise systems, facilitating entity mapping and the automation of complex customer journeys. By providing a customer data platform alongside a customer journey orchestration engine and analytics capabilities, Usermind enables organizations to deliver data-driven, omnichannel engagement throughout the customer lifecycle. This comprehensive approach empowers businesses to increase revenue, enhance customer engagement, and optimize costs.
Notable Labs
Venture Round in 2019
Notable Labs, Inc. is a clinical-stage company that specializes in personalized lab testing services for cancer patients, particularly those with brain cancer. Founded in 2014 and based in Foster City, California, the company utilizes its proprietary Predictive Precision Medicines Platform to conduct drug combination experiments on patients' tumors. This platform allows Notable Labs to simulate cancer treatments and predict patient responses to specific therapies, enabling healthcare providers to prioritize combinations of FDA-approved treatments that can be prescribed without the need for clinical trials. By providing detailed reports to physicians, Notable Labs aims to enhance treatment efficacy and expedite therapeutic development for patients.
Datanomix
Series A in 2019
Datanomix, Inc. is a software company based in Nashua, New Hampshire, established in 2015. It specializes in providing a machine data analytics platform that delivers real-time insights into manufacturing productivity for industrial manufacturers. The company's software integrates machine data streams, extending its functionality beyond conventional data visualization and process productivity tools. This allows manufacturers of all sizes to access advanced decision-making resources, thereby enhancing their production efficiency, performance, and profitability. By focusing on production intelligence, Datanomix aims to support the next generation of manufacturing environments.
Pienso
Venture Round in 2019
Pienso Inc. is a machine learning platform that transforms text data into actionable insights, catering specifically to non-programming analysts, researchers, and domain experts. The platform employs advanced machine learning algorithms known as lensing to enhance both algorithmic processes and user interactions, facilitating real-time validation and adaptation. It incorporates feedback loops that enable continuous improvement through user and machine collaboration. Additionally, Pienso utilizes APIs to integrate data from existing applications, streamlining the creation and management of machine learning processes. Founded in 2016 and headquartered in Brooklyn, New York, Pienso was previously known as UBQ Labs, Inc.
Olaris
Venture Round in 2019
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.